Home
>
Isotope Labeled Compounds>Other Isotope Labeled Compounds>
>
(2R,4R,5R,7S)-Aliskiren-d6 Fumarate (2:1)
For research use only. Not for therapeutic Use.
(2R,4R,5R,7S)-Aliskiren-d6 Fumarate (2:1)(Cat No.:R028041) is a high-purity deuterated compound crucial for advanced pharmaceutical and biochemical research. This isotopically labeled version of Aliskiren features six deuterium atoms, enhancing its stability and precision in analytical and clinical applications. It is essential for studies involving renin inhibition, hypertension treatment, and drug metabolism. The stable isotope labeling ensures accurate and reliable results, making it ideal for various experimental setups. Perfect for cardiovascular research and drug development, (2R,4R,5R,7S)-Aliskiren-d6 Fumarate (2:1) integrates seamlessly into existing protocols, providing a robust solution for high-precision scientific investigations.
Catalog Number | R028041 |
CAS Number | NA |
Synonyms | (αR,γR,δR,ζS)-δ-Amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)benzeneoctanamide-d6 (2E)-2-Butenedioate (2:1) |
Molecular Formula | C₆₄H₉₈D₁₂N₆O₁₆ |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | (2R,4R,5R,7S)-5-amino-N-[2-carbamoyl-3,3,3-trideuterio-2-(trideuteriomethyl)propyl]-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide;(E)-but-2-enedioic acid |
InChI | InChI=1S/2C30H53N3O6.C4H4O4/c2*1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36;5-3(6)1-2-4(7)8/h2*10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35);1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*22-,23+,24+,25+;/m00./s1/i2*5D3,6D3; |
InChIKey | KLRSDBSKUSSCGU-IBXSQNHYSA-N |
SMILES | [2H]C([2H])([2H])C(CNC(=O)[C@H](C[C@H]([C@@H](C[C@H](CC1=CC(=C(C=C1)OC)OCCCOC)C(C)C)N)O)C(C)C)(C(=O)N)C([2H])([2H])[2H].[2H]C([2H])([2H])C(CNC(=O)[C@H](C[C@H]([C@@H](C[C@H](CC1=CC(=C(C=C1)OC)OCCCOC)C(C)C)N)O)C(C)C)(C(=O)N)C([2H])([2H])[2H].C(=C/C(=O)O)\C(=O)O |